Literature DB >> 27925270

Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study.

Y Onda1, S Sugihara2, T Ogata3, S Yokoya4, T Yokoyama5, N Tajima6.   

Abstract

AIMS: A majority of children with Type 1 diabetes in Japan are registered with the government-subsidized Specified Pediatric Chronic Disease Treatment Research Projects (SPCDTRP). In this study, the incidence and prevalence of childhood-onset (< 15 years) Type 1 diabetes in Japan were estimated by drawing on SPCDTRP data.
METHODS: Data available for 2005-2012 from the SPCDTRP and Statistics Bureau, Ministry of Internal Affairs and Communications were used to estimate the incidence of Type 1 diabetes for 2005-2010, adjusted to cover those registered within 3 years of disease onset and stratified by sex, age at onset and period of onset.
RESULTS: The incidence of Type 1 diabetes for 2005-2010 was 2.25/100,000 persons [95% confidence intervals (95% CI), 2.14-2.36] (boys: 1.91, 95% CI, 1.83-1.98; girls: 2.52, 95% CI, 2.34-2.69), with that for the age brackets 0-4, 5-9 and 10-14 years being 1.48 (95% CI, 1.29-1.66), 2.27 (95% CI, 2.08-2.47) and 3.00 (95% CI, 2.74-3.25), respectively. The onset of disease was shown to peak at age 13 among boys (3.28, 95% CI, 3.02-3.55) and at age 10 among girls (3.28, 95% CI, 3.02-3.55). The peak periods of disease onset were April/May and December. The number of children aged < 15 years with Type 1 diabetes for 2005-2012 was estimated to be 2326 (95% CI, 2202-2450) with the prevalence estimated as 13.53/100,000 persons (95% CI, 12.63-14.43).
CONCLUSIONS: Study findings demonstrated no increase in the incidence of Type 1 diabetes, although suggesting, in agreement with earlier reports, that the onset of disease peaks in adolescence with a female predominance. In addition, the incidence of childhood-onset diabetes exhibited an annual bimodal pattern in this study.
© 2016 Diabetes UK.

Entities:  

Mesh:

Year:  2017        PMID: 27925270     DOI: 10.1111/dme.13295

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

1.  Current clinical state of type 1 diabetes in Saitama prefecture.

Authors:  Yoichi Oikawa; Koshi Hashimoto; Kazuo Hara; Jiro Morimoto; Kazuyuki Namai; Akihiko Tanaka; Satoshi Tanaka; Akira Shimada
Journal:  Diabetol Int       Date:  2021-11-01

2.  Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group.

Authors:  Itsuko Miyazawa; Hiroshi Maegawa; Aya Kadota; Takashi Nakamura; Makoto Konishi; Shinichi Ochi; Katsuyuki Miura; Motozumi Okamoto
Journal:  Diabetol Int       Date:  2022-02-17

3.  Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types.

Authors:  Tomoko Takai; Yuko Okada; Reiko Takebe; Takehiro Nakamura
Journal:  Diabetol Int       Date:  2021-09-05

4.  Incidence of type 1 diabetes in China, 2010-13: population based study.

Authors:  Jianping Weng; Zhiguang Zhou; Lixin Guo; Dalong Zhu; Linong Ji; Xiaoping Luo; Yiming Mu; Weiping Jia
Journal:  BMJ       Date:  2018-01-03

5.  Incidence of Type 1 Diabetes in Children Aged Below 18 Years during 2013-2015 in Northwest Turkey

Authors:  Şükran Poyrazoğlu; Rüveyde Bundak; Zehra Yavaş Abalı; Hasan Önal; Sevil Sarıkaya; Abdurrahman Akgün; Serpil Baş; Saygın Abalı; Abdullah Bereket; Erdal Eren; Ömer Tarım; Ayla Güven; Metin Yıldız; Derya Karaman Aksakal; Ayşegül Yüksel; Gülcan Seymen Karabulut; Şükrü Hatun; Tolga Özgen; Yaşar Cesur; Mehmet Azizoğlu; Emine Dilek; Filiz Tütüncüler; Esra Papatya Çakır; Bahar Özcabı; Olcay Evliyaoğlu; Songül Karadeniz; Fatma Dursun; Semih Bolu; İlknur Arslanoğlu; Gül Yeşiltepe Mutlu; Heves Kırmızıbekmez; Pınar İşgüven; Ala Üstyol; Erdal Adal; Ahmet Uçar; Nurcan Cebeci; Didem Bezen; Çiğdem Binay; Serap Semiz; Hüseyin Anıl Korkmaz; Nihal Memioğlu; Elif Sağsak; Havva Nur Peltek; Melek Yıldız; Teoman Akçay; Serap Turan; Tülay Güran; Zeynep Atay; Neşe Akcan; Filiz Çizmecioğlu; Oya Ercan; Aydilek Dağdeviren; Firdevs Baş; Halim İşsever; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-05-23

6.  Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.

Authors:  Jiqun Wang; Shudong Wang; Wanning Wang; Jing Chen; Zhiguo Zhang; Qi Zheng; Quan Liu; Lu Cai
Journal:  J Cell Mol Med       Date:  2019-07-03       Impact factor: 5.310

7.  Type 1 Diabetes Accelerates Progression of Coronary Artery Calcium Over the Menopausal Transition: The CACTI Study.

Authors:  Amena Keshawarz; Laura Pyle; Amy Alman; Caprice Sassano; Elizabeth Westfeldt; Rachel Sippl; Janet Snell-Bergeon
Journal:  Diabetes Care       Date:  2019-09-26       Impact factor: 19.112

8.  Increased diagnosis of autoimmune childhood-onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme-linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit.

Authors:  Shigetaka Sugihara; Ichiro Yokota; Tokuo Mukai; Takahiro Mochizuki; Masashi Nakayama; Emiko Tachikawa; Yasumasa Kawada; Kinship Minamitani; Nobuyuki Kikuchi; Tatsuhiko Urakami; Tomoyuki Kawamura; Eiji Kawasaki; Toru Kikuchi; Shin Amemiya
Journal:  J Diabetes Investig       Date:  2019-12-24       Impact factor: 4.232

9.  Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan.

Authors:  Yuichi Nishioka; Tatsuya Noda; Sadanori Okada; Tomoya Myojin; Shinichiro Kubo; Tsuneyuki Higashino; Hitoshi Ishii; Tomoaki Imamura
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

10.  Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report.

Authors:  Ryuzoh Nishizono; Hiroki Kogou; Yuri Ishizaki; Akihiro Minakawa; Masao Kikuchi; Hiroko Inagaki; Yuji Sato; Shouichi Fujimoto
Journal:  BMC Nephrol       Date:  2020-09-23       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.